French study examines pregnancy risks of common IBD drugs
NCT ID NCT03134508
Summary
This study looked at the safety of anti-TNF medications for pregnant women with inflammatory bowel diseases (IBD) like Crohn's disease and ulcerative colitis. Researchers analyzed French national health data from over 8,700 pregnancies to understand whether these medications help control the mother's disease without harming the baby. The goal was to provide clearer guidance on balancing treatment benefits against potential risks during pregnancy and the baby's first year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chu de Dijon
Dijon, France
Conditions
Explore the condition pages connected to this study.